119 related articles for article (PubMed ID: 29908145)
1. Influence of multiple delays in brain tumor and immune system interaction with T11 target structure as a potent stimulator.
Khajanchi S; Banerjee S
Math Biosci; 2018 Aug; 302():116-130. PubMed ID: 29908145
[TBL] [Abstract][Full Text] [Related]
2. Quantifying the role of immunotherapeutic drug T11 target structure in progression of malignant gliomas: Mathematical modeling and dynamical perspective.
Khajanchi S; Banerjee S
Math Biosci; 2017 Jul; 289():69-77. PubMed ID: 28461156
[TBL] [Abstract][Full Text] [Related]
3. A mathematical model to elucidate brain tumor abrogation by immunotherapy with T11 target structure.
Banerjee S; Khajanchi S; Chaudhuri S
PLoS One; 2015; 10(5):e0123611. PubMed ID: 25955428
[TBL] [Abstract][Full Text] [Related]
4. T11TS immunotherapy repairs PI3K-AKT signaling in T-cells: Clues toward enhanced T-cell survival in rat glioma model.
Chaudhuri S; Singh MK; Bhattacharya D; Datta A; Hazra I; Mondal S; Faruk Sk Md O; Ronsard L; Ghosh TK; Chaudhuri S
J Cell Physiol; 2018 Feb; 233(2):759-770. PubMed ID: 28608562
[TBL] [Abstract][Full Text] [Related]
5. Disease relevance of T11TS-induced T-cell signal transduction through the CD2-mediated calcineurin-NFAT pathway: Perspectives in glioma immunotherapy.
Chaudhuri S; Bhattacharya D; Singh MK; Moitra S; Ronsard L; Ghosh TK; Chaudhuri S
Mol Immunol; 2015 Oct; 67(2 Pt B):256-64. PubMed ID: 26105805
[TBL] [Abstract][Full Text] [Related]
6. CD2-SLFA3/T11TS interaction facilitates immune activation and glioma regression by apoptosis.
Sarkar S; Ghosh A; Mukherjee J; Chaudhuri S; Chaudhuri S
Cancer Biol Ther; 2004 Nov; 3(11):1121-8. PubMed ID: 15467439
[TBL] [Abstract][Full Text] [Related]
7. The novel immunotherapeutic molecule T11TS modulates glioma-induced changes of key components of the immunological synapse in favor of T cell activation and glioma abrogation.
Chaudhuri S; Singh MK; Bhattacharya D; Acharya S; Chatterjee S; Kumar P; Bhattacharjee P; Basu AK; Sa G; Das T; Ghosh TK; Chaudhuri S
J Neurooncol; 2014 Oct; 120(1):19-31. PubMed ID: 25026997
[TBL] [Abstract][Full Text] [Related]
8. T11 target structure exerts effector function by activating immune cells in CNS against glioma where cytokine modulation provide favorable microenvironment.
Ghosh A; Bhattacharya M; Sarkar P; Acharya S; Chaudhuri S
Indian J Exp Biol; 2010 Sep; 48(9):879-88. PubMed ID: 21506495
[TBL] [Abstract][Full Text] [Related]
9. T11TS repress gliomagenic apoptosis of bone marrow hematopoietic stem cells.
Mondal S; Hazra I; Datta A; Sk Md OF; Moitra S; Tripathi SK; Chaudhuri S
J Cell Physiol; 2018 Jan; 233(1):269-290. PubMed ID: 28233371
[TBL] [Abstract][Full Text] [Related]
10. Significant modulation of macrophages associated cytokines TNF-α, VEGF and apoptotoic protein Bax, Bcl2 abrogates tumor cells.
Kumar P; Chatterjee S; Acharya S; Kumari A; Chaudhuri S; Singh MK; Ghosh SN; Chaudhuri S
Cell Immunol; 2013; 284(1-2):172-81. PubMed ID: 23994239
[TBL] [Abstract][Full Text] [Related]
11. T11 target structure induced modulations of the pro-inflammatory and anti-infammatorycytokine expressions in experimental animals for glioma abrogation.
Singh MK; Chaudhuri S; Bhattacharya D; Kumar P; Datta A; Chaudhuri S
Int Immunopharmacol; 2015 Feb; 24(2):198-207. PubMed ID: 25528475
[TBL] [Abstract][Full Text] [Related]
12. When Immune Cells Turn Bad-Tumor-Associated Microglia/Macrophages in Glioma.
Roesch S; Rapp C; Dettling S; Herold-Mende C
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29389898
[TBL] [Abstract][Full Text] [Related]
13. Periodic and chaotic oscillations in a tumor and immune system interaction model with three delays.
Bi P; Ruan S; Zhang X
Chaos; 2014 Jun; 24(2):023101. PubMed ID: 24985415
[TBL] [Abstract][Full Text] [Related]
14. Dendritic cell-based immunotherapy for malignant gliomas.
Akasaki Y; Black KL; Yu JS
Expert Rev Neurother; 2005 Jul; 5(4):497-508. PubMed ID: 16026233
[TBL] [Abstract][Full Text] [Related]
15. T11TS immunotherapy augments microglial and lymphocyte protective immune responses against Cryptococcus neoformans in the brain.
Hazra I; Sk Md OF; Datta A; Mondal S; Moitra S; Singh MK; Chaudhuri S; Das PK; Basu AK; Dhar I; Basu N; Chaudhuri S
Scand J Immunol; 2019 Feb; 89(2):e12733. PubMed ID: 30450625
[TBL] [Abstract][Full Text] [Related]
16. The mixed human umbilical cord blood-derived mesenchymal stem cells show higher antitumor effect against C6 cells than the single in vitro.
Jiao H; Yang B; Guan F; Li J; Shan H; Song L; Hu X; Liang S; Du Y; Jiang C
Neurol Res; 2011 May; 33(4):405-14. PubMed ID: 21535940
[TBL] [Abstract][Full Text] [Related]
17. Immune stimulatory effects of CD70 override CD70-mediated immune cell apoptosis in rodent glioma models and confer long-lasting antiglioma immunity in vivo.
Aulwurm S; Wischhusen J; Friese M; Borst J; Weller M
Int J Cancer; 2006 Apr; 118(7):1728-35. PubMed ID: 16217761
[TBL] [Abstract][Full Text] [Related]
18. Animal models for vaccine therapy.
Chung DS; Kim CH; Hong YK
Adv Exp Med Biol; 2012; 746():143-50. PubMed ID: 22639165
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy of malignant gliomas.
Maleci A
J Neurosurg Sci; 1989; 33(1):77-82. PubMed ID: 2674361
[TBL] [Abstract][Full Text] [Related]
20. Basic concepts in glioma immunology.
Parney IF
Adv Exp Med Biol; 2012; 746():42-52. PubMed ID: 22639158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
